Literature DB >> 6448581

In vitro activity of cefoperazone against nonfermenters and Aeromonas hydrophila.

R J Fass.   

Abstract

The in vitro activity of cefoperazone against 380 strains (33 species and unnamed groups) of nonferenters and 20 strains of Aeromonas hydrophila was studied by a microdilution method of determining minimal inhibitory concentrations. For comparison, the activities of ampicillin, ticarcillin, and cefamandole were simultaneously studied. Cefoperazone was the most active drug against Pseudomonas sp., Achromobacter xylosoxidans, Flavobacterium meningosepticum. Flavobacterium sp. (group IIb), Group IVc biotype 2, Group Ve, and Aeromonas hydrophila. Against other organisms it was equivalent in activity to or less active than comparative antibiotics. The only organisms which were usually resistant to 128 microgram of cefoperazone per ml were strains of Flavobacterium odoratum and Group IIk biotype 1.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6448581      PMCID: PMC284028          DOI: 10.1128/AAC.18.3.483

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.

Authors:  C N Baker; C Thornsberry; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

2.  Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.

Authors:  W H Hall; B J Opfer; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

3.  Rapid identification of nonfermentative gram-negative rods by the Corning N/F system.

Authors:  J Barnishan; L W Ayers
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

4.  Comparative activity and beta-lactamase stability of cefoperazone, a piperazine cephalosporin.

Authors:  H C Neu; K P Fu; N Aswapokee; P Aswapokee; K Kung
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

5.  In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin.

Authors:  N Matsubara; S Minami; T Muraoka; I Saikawa; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

6.  Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.

Authors:  S D Lang; D J Edwards; D T Durack
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

7.  Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.

Authors:  M V Borobio; J Aznar; R Jimenez; F Garcia; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

8.  In vitro evaluation of cefoperazone.

Authors:  A M Hinkle; B M LeBlanc; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

9.  Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin.

Authors:  R N Jones; P C Fuchs; A L Barry; T L Gavan; H M Sommers; E H Gerlach
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

  9 in total
  8 in total

1.  In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli.

Authors:  R J Fass; J Barnishan; M C Solomon; L W Ayers
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

2.  Antimicrobial susceptibility of Bordetella avium and Bordetella bronchiseptica isolates.

Authors:  J E Mortensen; A Brumbach; T R Shryock
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

3.  Effect of temperature on antimicrobial susceptibilities of Pseudomonas maltophilia.

Authors:  P F Wheat; T G Winstanley; R C Spencer
Journal:  J Clin Pathol       Date:  1985-09       Impact factor: 3.411

4.  In vitro susceptibilities of Aeromonas hydrophila to 32 antimicrobial agents.

Authors:  R J Fass; J Barnishan
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

5.  In vitro susceptibilities of Aeromonas hydrophila against new antibiotics.

Authors:  V Fainstein; S Weaver; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

6.  Sensitivity of 341 non-fermentative gram-negative bacteria to seven beta-lactam antibiotics.

Authors:  P C Appelbaum; J Tamim; J Stavitz; R C Aber; G A Pankuch
Journal:  Eur J Clin Microbiol       Date:  1982-06       Impact factor: 3.267

7.  Comparison of cefoperazone with penicillin, ampicillin, gentamicin, and chloramphenicol in the therapy of experimental meningitis.

Authors:  W M Scheld; J P Brodeur; M A Sande; G M Alliegro
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

8.  Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency.

Authors:  W K Bolton; W M Scheld; D A Spyker; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.